rapilysin
actavis group ptc ehf - retepláza - infarkt myokardu - antitrombotické činidlá - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.
pleumolysin
teva czech industries s.r.o., Česká republika - Ópiové deriváty a mukolytiká - 52 - expectorantia, mucolytica
lisinopril-ratiopharm 5 mg
ratiopharm gmbh, nemecko - lizinopril - 58 - hypotensiva
lisinopril-ratiopharm 10 mg
ratiopharm gmbh, nemecko - lizinopril - 58 - hypotensiva
lisinopril-ratiopharm 20 mg
ratiopharm gmbh, nemecko - lizinopril - 58 - hypotensiva
lisinopril grindeks 20 mg tablety
as grindeks, lotyšsko - lizinopril - 58 - hypotensiva
lisinopril grindeks 10 mg tablety
as grindeks, lotyšsko - lizinopril - 58 - hypotensiva
lisinopril grindeks 5 mg tablety
as grindeks, lotyšsko - lizinopril - 58 - hypotensiva
lysini hydrochloridum 40 000 mg, d,l- methioninum 30 000 mg, retinoli acetas 400 000 iu, thiaminum 50 mg, riboflavinum 80 mg, pyridoxini hydrochloridum 70 mg, cyanocobalaminum 0,5 mg, acidum nicotinicum 600 mg, biotinum 10 mg, cholini chloridum 12 000 mg, calcii pantothenas 350 mg, colecalciferolum 60 000 iu, tocoferoli alfa acetas 400 mg, menadionum 40 mg, calcii hydrogenphosphas 250 000 mg, natrii chloridum 25 000 mg, ferrosi sulfas 3 200 mg, cupri sulfas 130 mg, zinci oxidum 1 200 mg, mangani carbonas 1 000 mg, kalii iodidum 10 mg, cobalti chloridum 8 mg, bioplex ferrosi 1 800 mg, bioplex cupri 150 mg, bioplex zinci 1 600 mg, bioplex mangani 1 200 mg, bioplex cobalti 30 mg, selplex 50 (selenis) 3 000 mg, antioxidanti 200 mg, vehiculum ad 1,00 kg.